Lottery ticketThe first draw of the Lottery Ticket bought by previoys management was drawn at the beginning of December was not a winning ticket...Admittedly the potential benifit appeared to be very high compared to the low purchase cost of the lottery ticket when our former Ceo bought Katana.... Recall that Katana had tried to find a Buyer for over a year with no takers!!!So what appeared to be low acquisition cost turned out to be a major distraction which also involved millions $$ in pre clinical and clinical costs and which compounded the negative impact of the Company opting to issue a Convetrt instead of issuing Stock at 11usd or 14 Cad .BTW the dark cloud of the Convert is still there and the recent Finanving only allows to kick part of the can down the road.
I said afer the Pause that Paul's next move will determine his Legacy.... I really like how he described the path forward but still want to see if he will want to own the go path in oncology
The decision to buy Katana and improvise as an oncology company was apparently made by the former Ceo with no experts weighing in .... The current CEO will at least rely on knowledgeable oncology experts before determining the path forward for the Sort 1 platform and I trust it will be a rational decidion and not to create a distraction!!!
One cannot exclude a change in the C Suite in line with the New Mission